NCT04449653

Brief Summary

OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and heart rate variability, can be used to predict changes in lupus disease activity. You may receive a Withings Steel HR smartwatch as part of this study. The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 28, 2020

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

May 26, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 29, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

June 29, 2020

Status Verified

June 1, 2020

Enrollment Period

8 months

First QC Date

May 26, 2020

Last Update Submit

June 23, 2020

Conditions

Keywords

LupusSLE

Outcome Measures

Primary Outcomes (32)

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week two

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week three

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week four

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week five

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week six

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week seven

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week eight

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week nine

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week ten

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week eleven

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twelve

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week thirteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week fourteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week fifteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week sixteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week seventeen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week eighteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week nineteen

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-one

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-two

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-three

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-four

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-five

  • OASIS Wellness and Disease Questionnaire

    Basic Health Information and Systemic Lupus Erythematosus-specific questions over the time span of a week

    Week twenty-six

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month one

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month two

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month three

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month four

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month five

  • Short Form, 36 question form

    36 questions asking individuals questions about their general health and wellness, not disease-specific

    Month six

  • Withings Heartrate & Activity

    Patient activity, sleep quality, and heart rate collected by the wearable watch

    Continuously, for six months

Secondary Outcomes (25)

  • Heart rate variability

    Week two

  • Heart rate variability

    Week three

  • Heart rate variability

    Week four

  • Heart rate variability

    Week five

  • Heart rate variability

    Week six

  • +20 more secondary outcomes

Other Outcomes (1)

  • OASIS Baseline Questionnaire

    Baseline, entered only upon enrollment

Study Arms (1)

Lupus Cases

Individuals who are diagnosed with System Lupus Erythematosus and consent to the study will be placed in this cohort. Upon enrollment they will be given the opportunity to invite a non-SLE-diagnosed friend to enroll in the study as a healthy control. These individuals will answer weekly questions and receive a smartwatch to measure their physical activity.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Lupus is more common by 3.5-fold among minority groups, e.g., African Americans, than it is among European- Americans.Additionally more than 90% of diagnosed cases of lupus are women. We anticipate significant enrollment of female gender and minority populations reflecting this racial and disparity in disease occurrence rates. Participants will be enrolled from across the United States, with no specific geographic locations being targeted or preferred.

You may qualify if:

  • Female or male age 18 or older
  • Participant is currently not enrolled in another study
  • Able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures

You may not qualify if:

  • NOT able to understand the requirements of the study, provide written informed consent, including consent for the use and disclosure of research-related health information, and comply with the study data collection procedures
  • Known to be pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ryan Newhardt

Oklahoma City, Oklahoma, 73104, United States

RECRUITING

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Eldon Jupe, Ph.D.

    Progentec Diagnostics

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eldon Jupe, Ph.D.

CONTACT

Ryan Newhardt, B.S.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 26, 2020

First Posted

June 29, 2020

Study Start

April 28, 2020

Primary Completion

December 31, 2020

Study Completion

June 1, 2021

Last Updated

June 29, 2020

Record last verified: 2020-06

Locations